UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
(Exact Name of Registrant as Specified in Charter)
|
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
|
|
|
(Address, including zip code, of Principal Executive Offices)
Registrant’s telephone number,
including area code: ( |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class: | Trading Symbol(s) | Name of each exchange on which registered: | ||
| The Global Market | ||||
| The Global Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
| Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 5.07. Submission of Matters to a Vote of Security Holders.
The 2022 annual meeting of stockholders (the “Annual Meeting”) of Healthcare Trust, Inc. (the “Company”) was held on May 12, 2022, at which there were present, in person or by proxy, stockholders holding an aggregate of 53,255,161 shares of the Company’s common stock, out of a total number of 100,735,691 shares of the Company’s common stock issued and outstanding and entitled to vote at the Annual Meeting, representing approximately 52.9% of the shares entitled to be voted.
At the Annual Meeting, the Company’s stockholders: (i) re-elected Edward G. Rendell and Elizabeth K. Tuppeny as Class II directors to serve until the Company’s 2025 annual meeting of stockholders and until their successors are duly elected and qualify; and (ii) ratified the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. The proposals are described in detail in the Company’s 2022 proxy statement. No other proposals were submitted to a vote of the Company’s stockholders at the Annual Meeting. The final results of the matters voted on at the Annual Meeting are set forth below:
Proposal 1 – Election of Class II Directors
| Nominee | For | Abstain | Withhold | Broker Non-Votes | ||||||||
| Edward G. Rendell | 16,931,424 | — | 2,565,004 | 33,758,733 | ||||||||
| Elizabeth K. Tuppeny | 17,250,367 | — | 2,246,061 | 33,758,733 |
Proposal 2 – Ratification of the Appointment of PwC as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2022:
| For | Against | Abstain | Broker Non-Votes | |||
| 52,097,976 | 527,587 | 629,598 | * |
| * | No broker non-votes arose in connection with Proposal No. 2. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| HEALTHCARE TRUST, INC. | ||
| Date: May 12, 2022 | By: | /s/ Scott M. Lappetito |
|
Scott M. Lappetito Chief Financial Officer, Secretary and Treasurer | ||